Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy-Reference-Cited by-同舟云学术

Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy

Published:2023-09 Issue: Volume: Page:
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Torasawa Masahiro,Horinouchi Hidehito^ORCID,Nomura Shogo,Igawa Satoshi,Asai Maiko,Ishii Hidenobu,Wakui Hiroshi,Ushio Ryota,Asao Tetsuhiko,Namba Yukiko,Koyama Ryo,Hayakawa Daisuke,Katayama Isana,Matsuda Hironari,Sasaki Shinichi,Takahashi Kazuhisa,Hosomi Yukio,Naoki Katsuhiko,Ohe Yuichiro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Small-cell lung cancer;Rudin;Nat Rev Dis Primers,2021

2. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy;Giaccone;J Clin Oncol,1988

3. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer;Owonikoko;J Thorac Oncol,2012

4. Validation of standard definition of sensitive versus refractory relapsed small cell lung cancer: a pooled analysis of topotecan second-line trials;Ardizzoni;Eur J Cancer,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study;Lung Cancer;2024-08

2. The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics;Genes;2024-05-27

3. A Response to the Letter to the Editor: “A Paradigm Shift in First-Line Treatment Can Have Many Implications for Second-Line Treatment”;Journal of Thoracic Oncology;2024-02

4. A Paradigm Shift in First-Line Treatment Can Have Many Implications For Second-Line Treatment;Journal of Thoracic Oncology;2024-02

5. SCLC Classification by Platinum Sensitivity in the Era of Immunotherapy: Mere Relic or a Valuable Treasure to Keep?;Journal of Thoracic Oncology;2024-02